National Lipid Association Statement: Enhancing the Value of PCSK9 Monoclonal Antibodies by Identifying Patients Most Likely to Benefit
Jennifer Robinson, MD, MPH
Chair, Value & Access Steering Committee
Director, Preventive Intervention Center
Professor, Departments of Epidemiology & Medicine
University of Iowa
Q & A
Jen Childress
Senior Public Health Consultant
National Forum for Heart Disease & Stroke Prevention
Presentation
Webinar Recording
Q & A Recording
Webinar Slides
Resources Referenced in Presentation
National Lipid Association: Enhancing the Value of PCSK9 Monoclonal Antibodies by Identifying Patients Most Likely to Benefit Resource Page (including manuscript and infographic)